Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.310
-0.010 (-0.76%)
At close: Feb 27, 2026, 4:00 PM EST
1.310
0.00 (-0.01%)
After-hours: Feb 27, 2026, 7:52 PM EST
Akebia Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 184.84 | 51.87 | 42.93 | 90.47 | 149.8 | Upgrade
|
| Cash & Short-Term Investments | 184.84 | 51.87 | 42.93 | 90.47 | 149.8 | Upgrade
|
| Cash Growth | 256.36% | 20.84% | -52.55% | -39.61% | -44.25% | Upgrade
|
| Receivables | 47.03 | 34.37 | 39.29 | 40.28 | 55.89 | Upgrade
|
| Inventory | 15.61 | 16.24 | 15.69 | 21.57 | 36.63 | Upgrade
|
| Prepaid Expenses | 5.47 | 4.03 | 14.49 | 15.62 | 28.83 | Upgrade
|
| Other Current Assets | - | 7.32 | 5.75 | 17.25 | - | Upgrade
|
| Total Current Assets | 252.96 | 113.83 | 118.15 | 185.18 | 271.15 | Upgrade
|
| Property, Plant & Equipment | 4.89 | 10.42 | 16.05 | 34.37 | 40.61 | Upgrade
|
| Goodwill | 59.04 | 59.04 | 59.04 | 59.04 | 59.04 | Upgrade
|
| Other Intangible Assets | - | - | 36.04 | 72.08 | 108.13 | Upgrade
|
| Other Long-Term Assets | 59.68 | 37.38 | 12.42 | 5.37 | 50.42 | Upgrade
|
| Total Assets | 376.57 | 220.67 | 241.7 | 356.05 | 529.35 | Upgrade
|
| Accounts Payable | 21.19 | 15.18 | 14.64 | 18.02 | 33.59 | Upgrade
|
| Accrued Expenses | 121.72 | 33.27 | 42.94 | 53.92 | 97.51 | Upgrade
|
| Current Portion of Long-Term Debt | 17.36 | 4.31 | 19.55 | 32 | 97.54 | Upgrade
|
| Current Portion of Leases | - | 5.4 | 4.49 | 4.74 | 4.8 | Upgrade
|
| Current Unearned Revenue | 2.68 | - | - | 3.74 | 20.91 | Upgrade
|
| Other Current Liabilities | - | 22.75 | 18.26 | 17.12 | 6.7 | Upgrade
|
| Total Current Liabilities | 162.94 | 80.91 | 99.87 | 129.54 | 261.05 | Upgrade
|
| Long-Term Debt | 176.21 | 175.47 | 111.29 | 91.56 | 53.08 | Upgrade
|
| Long-Term Leases | - | 3.55 | 8.95 | 28.96 | 33.7 | Upgrade
|
| Long-Term Unearned Revenue | - | - | 43.3 | 43.3 | 21.47 | Upgrade
|
| Other Long-Term Liabilities | 4.8 | 9.93 | 8.89 | 57.47 | 86.03 | Upgrade
|
| Total Liabilities | 343.96 | 269.86 | 272.29 | 350.82 | 455.34 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 1,716 | 1,629 | 1,578 | 1,562 | 1,537 | Upgrade
|
| Retained Earnings | -1,684 | -1,678 | -1,609 | -1,557 | -1,463 | Upgrade
|
| Comprehensive Income & Other | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Shareholders' Equity | 32.61 | -49.19 | -30.58 | 5.23 | 74.01 | Upgrade
|
| Total Liabilities & Equity | 376.57 | 220.67 | 241.7 | 356.05 | 529.35 | Upgrade
|
| Total Debt | 193.57 | 188.73 | 144.28 | 157.27 | 189.13 | Upgrade
|
| Net Cash (Debt) | -8.73 | -136.86 | -101.35 | -66.8 | -39.33 | Upgrade
|
| Net Cash Per Share | -0.03 | -0.65 | -0.54 | -0.37 | -0.24 | Upgrade
|
| Filing Date Shares Outstanding | 267.88 | 236.23 | 209.37 | 184.25 | 181.23 | Upgrade
|
| Total Common Shares Outstanding | 265.42 | 224.85 | 194.58 | 184.14 | 177 | Upgrade
|
| Working Capital | 90.02 | 32.92 | 18.28 | 55.65 | 10.1 | Upgrade
|
| Book Value Per Share | 0.12 | -0.22 | -0.16 | 0.03 | 0.42 | Upgrade
|
| Tangible Book Value | -26.43 | -108.23 | -125.67 | -125.9 | -93.16 | Upgrade
|
| Tangible Book Value Per Share | -0.10 | -0.48 | -0.65 | -0.68 | -0.53 | Upgrade
|
| Machinery | - | - | - | - | 5.85 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 8.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.